PT-141 10MG

PT-141 (Bremelanotide) is a research peptide that acts on melanocortin receptors in the central nervous system and is widely studied for its role in sexual desire and arousal pathways. Unlike compounds that work through vascular mechanisms, PT-141 is believed to influence libido through neurological signaling in the brain.

Research interest in PT-141 has largely focused on its potential effects on:

• Sexual desire and arousal pathways in both male and female models
• Central melanocortin receptor activity (MC3R and MC4R)
• Dopamine-related reward and motivation signaling
• Hypoactive sexual desire disorder (HSDD) research models
• Non-vascular pathways of sexual function regulation

Clinical studies of Bremelanotide have explored its effects in women with hypoactive sexual desire disorder (HSDD), where increases in sexual desire and reduced distress related to low libido were observed in a portion of study participants. Because of its central nervous system mechanism, it is considered distinct from traditional vasodilatory approaches.

Manufactured to strict research-grade standards, PT-141 is produced for purity, consistency, and reliability in advanced laboratory and investigational research applications.

Key Features

• Research-grade melanocortin receptor peptide
• Studied for sexual desire and arousal pathway research
• Investigated in HSDD-related clinical models
• Central (non-vascular) mechanism of action
• Intended exclusively for laboratory and investigational use

Disclaimer

This product is intended for laboratory research purposes only. This product is not approved by the FDA for human consumption, diagnosis, treatment, cure, or prevention of any disease. Not for medical or veterinary use.